145 related articles for article (PubMed ID: 38497717)
1. Th1 cell immune response in
Qiu Y; Li Z-T; Zeng W; Yang J-L; Tang M-X; Wang Y; Wang H-R; Li Y; Zhan Y-Q; Li S-Q; Zhang J-Q; Ye F
Microbiol Spectr; 2024 May; 12(5):e0364623. PubMed ID: 38497717
[TBL] [Abstract][Full Text] [Related]
2. Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections.
Guo J; Ning XQ; Ding JY; Zheng YQ; Shi NN; Wu FY; Lin YK; Shih HP; Ting HT; Liang G; Lu XC; Kong JL; Wang K; Lu YB; Fu YJ; Hu R; Li TM; Pan KS; Li XY; Huang CY; Lo YF; Chang IY; Yeh CF; Tu KH; Tsai YH; Ku CL; Cao CW
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32880631
[TBL] [Abstract][Full Text] [Related]
3. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.
Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F
BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700
[TBL] [Abstract][Full Text] [Related]
4. Talaromyces marneffei and Mycobacterium tuberculosis co-infection in a patient with high titer anti-interferon-γ autoantibodies: a case report.
Qiu Y; Pan M; Yang Z; Zeng W; Zhang H; Li Z; Zhang J
BMC Infect Dis; 2022 Jan; 22(1):98. PubMed ID: 35090402
[TBL] [Abstract][Full Text] [Related]
5. Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated
Lee PP; Lao-Araya M; Yang J; Chan KW; Ma H; Pei LC; Kui L; Mao H; Yang W; Zhao X; Trakultivakorn M; Lau YL
Front Immunol; 2019; 10():2189. PubMed ID: 31572394
[No Abstract] [Full Text] [Related]
6. Clinical findings and predictive factors for positive anti-interferon-γ autoantibodies in patients suffering from a non-tuberculosis mycobacteria or Talaromyces marneffei infection: a multicenter prospective cohort study.
Qiu Y; Tang M; Zeng W; Feng X; Pan M; Li W; Zhang J
Sci Rep; 2022 May; 12(1):9069. PubMed ID: 35641599
[TBL] [Abstract][Full Text] [Related]
7. Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with
Chen ZM; Yang XY; Li ZT; Guan WJ; Qiu Y; Li SQ; Zhan YQ; Lei ZY; Liu J; Zhang JQ; Wang ZF; Ye F
Infect Drug Resist; 2022; 15():3381-3393. PubMed ID: 35789796
[TBL] [Abstract][Full Text] [Related]
8. Talaromyces marneffei infection relapse presenting as osteolytic destruction followed by suspected nontuberculous mycobacterium infection during 6 years of follow-up: A case update.
Liang X; Si L; Li Y; Zhang J; Deng J; Bai J; Li M; He Z
Int J Infect Dis; 2020 Apr; 93():208-210. PubMed ID: 32105768
[TBL] [Abstract][Full Text] [Related]
9. Role of autophagy in regulating the immune response of dendritic cells to Talaromyces marneffei infection.
Chen R; Ji G; Xi L; Zhang T; Zheng D; Li X; Ren H
Microb Pathog; 2018 Oct; 123():120-125. PubMed ID: 29964152
[TBL] [Abstract][Full Text] [Related]
10. Case report: Diagnosis of
Du R; Feng Y; Mao H
Front Cell Infect Microbiol; 2023; 13():1163846. PubMed ID: 37469600
[TBL] [Abstract][Full Text] [Related]
11. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study.
Jiang J; Meng S; Huang S; Ruan Y; Lu X; Li JZ; Wu N; Huang J; Xie Z; Liang B; Deng J; Zhou B; Chen X; Ning C; Liao Y; Wei W; Lai J; Ye L; Wu F; Liang H
Clin Microbiol Infect; 2019 Feb; 25(2):233-241. PubMed ID: 29698815
[TBL] [Abstract][Full Text] [Related]
12. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.
Chan JF; Lau SK; Yuen KY; Woo PC
Emerg Microbes Infect; 2016 Mar; 5(3):e19. PubMed ID: 26956447
[TBL] [Abstract][Full Text] [Related]
13. Coinfection by
Jin W; Liu J; Chen K; Shen L; Zhou Y; Wang L
J Int Med Res; 2021 Jan; 49(1):300060520976471. PubMed ID: 33435770
[TBL] [Abstract][Full Text] [Related]
14.
Lin F; Yang Z; Qiu Y; Zeng W; Liu G; Zhang J
Infect Drug Resist; 2021; 14():5005-5013. PubMed ID: 34866920
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Cyclophosphamide Therapy for Anti-IFN-γ Autoantibody-Associated
Zeng W; Tang M; Yang M; Fang G; Tang S; Zhang J
Open Forum Infect Dis; 2022 Dec; 9(12):ofac612. PubMed ID: 36519123
[TBL] [Abstract][Full Text] [Related]
16. Pathogen spectrum and immunotherapy in patients with anti-IFN-γ autoantibodies: A multicenter retrospective study and systematic review.
Qiu Y; Fang G; Ye F; Zeng W; Tang M; Wei X; Yang J; Li Z; Zhang J
Front Immunol; 2022; 13():1051673. PubMed ID: 36569827
[TBL] [Abstract][Full Text] [Related]
17. Accurate diagnosis of bronchopulmonary
Chen G; Ma N; Zhu D; Zhou H; Liang Q; Meng J; Shen Y; Liu H; Liu L; He Z; Qin Z
Front Cell Infect Microbiol; 2023; 13():1186335. PubMed ID: 37860065
[TBL] [Abstract][Full Text] [Related]
18. A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis.
Wongkamhla T; Chongtrakool P; Jitmuang A
BMC Infect Dis; 2019 Dec; 19(1):1034. PubMed ID: 31805893
[TBL] [Abstract][Full Text] [Related]
19. Interplay of interferon-gamma and macrophage polarization during Talaromyces marneffei infection.
Lu S; Li D; Xi L; Calderone R
Microb Pathog; 2019 Sep; 134():103594. PubMed ID: 31199985
[TBL] [Abstract][Full Text] [Related]
20. Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies.
Li S; Cao X; Guo Z; Wang J; Tong J; Zhang Z
An Bras Dermatol; 2024; 99(2):233-237. PubMed ID: 37926601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
